Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2005
03/10/2005WO2005022168A2 Hematological analyzer on whole blood with stirring device
03/10/2005WO2005022167A2 Compounds that act to modulate insect growth and methods and systems for identifying such compounds
03/10/2005WO2005022166A1 Protein crystalline state judging method and its system
03/10/2005WO2005022165A1 Analysis of molecules
03/10/2005WO2005022163A2 Method for determining adult neurogenesis
03/10/2005WO2005022162A1 Quantum dots and methods of use thereof
03/10/2005WO2005022161A1 Chemiluminescent compounds
03/10/2005WO2005022160A2 Diagnosis and treatment of micobacterial infections
03/10/2005WO2005022158A1 Device for detecting biochemical activity containing gap junctions
03/10/2005WO2005022157A1 Evaluation of adjuvanted vaccines
03/10/2005WO2005022156A1 Method of protein immobilization
03/10/2005WO2005022155A1 Color reagent, concentration measuring kit, method of concentration measuring and sensor chip for use therein
03/10/2005WO2005022154A1 Biosensor and method of analyte measuring
03/10/2005WO2005022152A1 Process for conjugating biomolecules to hydrophobic membrane-incorporated molecules
03/10/2005WO2005022151A1 Film layer for detection of immobilized analytes
03/10/2005WO2005022150A2 Assay methods and materials for distinguishing analytes and analyte analogues
03/10/2005WO2005022149A1 Method for determining embryo quality
03/10/2005WO2005022148A1 Method for the in vitro titration of an ncta and application thereof in a method for the evaluation and/or monitoring of a biological product production method
03/10/2005WO2005022147A1 Methods and apparatus for sorting cells using an optical switch in a microfluidic channel network
03/10/2005WO2005022146A2 Diagnostics and therapeutics for diseases associated with kallikrein 13 (klk13)
03/10/2005WO2005022145A2 Remote contamination monitoring system for water supply network
03/10/2005WO2005022143A2 Method and apparatus for assay of electrochemical properties
03/10/2005WO2005022142A1 Biomolecule detecting element and method for analyzing nucleic acid using the same
03/10/2005WO2005022139A1 An novel test strip, the method for its manufacture and the use thereof
03/10/2005WO2005022129A1 Sensor for detecting a target substance in a fluid
03/10/2005WO2005022125A1 Integrated apparatus for hematological analyses and related method
03/10/2005WO2005022122A2 Indirect measurement of diluents in a multi-component natural gas
03/10/2005WO2005022121A2 Measurement of nitrogen content in a gas mixture by transforming the nitrogen into a substance detectable with nondispersive infrared detection
03/10/2005WO2005022118A2 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics
03/10/2005WO2005022113A2 Ion channel assay methods
03/10/2005WO2005022111A2 A stochastic method to determine, in silico, the drug like character of molecules
03/10/2005WO2005022106A1 Pressure wave piezoelectric sensor
03/10/2005WO2005021801A2 Pathogenic gene for coronary artery disease
03/10/2005WO2005021799A2 Materials and methods for capture of pathogens and removal of aurintricarboxylic acid from a sample
03/10/2005WO2005021792A1 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient
03/10/2005WO2005021791A1 Method of evaluating effect of external stimulus by using vital cells, kit for performing the method and system of evaluating effect on external stimulus
03/10/2005WO2005021784A2 Estimation of activity or inhibition of processes involved in nucleic acid modification using chemiluminescence quenching
03/10/2005WO2005021780A1 Signal amplification using a synthetic zymogen
03/10/2005WO2005021779A1 Mass spectrometry methods for simultaneous detection of metabolic enzyme activity and metabolite levels
03/10/2005WO2005021753A1 Probe carrier and method for quantifying target substance using the probe carrier
03/10/2005WO2005021745A1 Hepatocellular cancer-associated gene
03/10/2005WO2005021744A1 Digital cell
03/10/2005WO2005021739A1 ANTIBODY AGAINST Nox1 POLYPEPTIDE, METHOD OF DIAGNOSING CANCER WITH THE USE OF Nox1 GENE AND METHOD OF SCREENING CANCER GROWTH INHIBITOR
03/10/2005WO2005021728A2 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations
03/10/2005WO2005021719A2 Libraries of recombinant chimeric proteins
03/10/2005WO2005021713A2 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
03/10/2005WO2005021709A2 Cln101 antibodies
03/10/2005WO2005021582A2 Methods for the early diagnosis of ovarian cancer
03/10/2005WO2005021576A2 Methods for for modeling gpcrs and for producing ligand blocking and receptor activating antibodies for same
03/10/2005WO2005021538A1 Novel chelating agents and chelates and their use
03/10/2005WO2005021501A1 Minimally invasive physiological function monitoring agents
03/10/2005WO2005021130A1 Method of detecting multiple analytes
03/10/2005WO2005021125A2 Optimization of electrospray ionization processes for use in discovery of proteomic patterns from biological samples
03/10/2005WO2005021025A2 MODULATION OF β-CATENIN/TCF ACTIVATED TRANSCRIPTION
03/10/2005WO2005020984A2 Method of reducing the risk of oxidative stress
03/10/2005WO2005020977A1 Alpha-ketoglutarate potentiators of insulin secretion
03/10/2005WO2005020924A2 A rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method
03/10/2005WO2005020922A2 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
03/10/2005WO2005020902A2 Compositions and methods for treating and diagnosing irritable bowel syndrome
03/10/2005WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005WO2005020888A2 Compositions and methods of treating and diagnosing hepatoma
03/10/2005WO2005020886A2 Identification and use of cofactor independent phosphoglycerate mutase as a drug target
03/10/2005WO2005020840A2 Composition and method for marking procaine penicillin
03/10/2005WO2005020799A2 METHOD FOR MEASURING FCϵRII/CD23 IGE RECEPTOR IN HUMAN FECES AS AN INDICATOR OF A TH2 PREDOMINANT IMMUNE RESPONSE INVOLVED IN GASTROINTESTINAL ILLNESSES
03/10/2005WO2005020796A2 Two-part drug discovery system
03/10/2005WO2005020794A2 Taxane chemosensitivity prediction test
03/10/2005WO2005020785A2 Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis
03/10/2005WO2005020681A1 Transgenic animal showing aging-related diseases associating with oxidation stress
03/10/2005WO2005012872A2 Liquid crystal based analyte detection
03/10/2005WO2005010533A3 Methods and kits for the detection of prion diseases
03/10/2005WO2005008247A3 Detection of endometrial pathology
03/10/2005WO2005008243A8 Sensing element for a biosensor
03/10/2005WO2005005960A3 High throughput one-hybrid system
03/10/2005WO2005003290A3 Methods and devices for determining a cell characteristic, and applications employing same
03/10/2005WO2005003172A3 Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy
03/10/2005WO2005001115A3 Monitoring gene silencing and annotating gene function in living cells
03/10/2005WO2004113912A8 System and method for determining a temperature during analysis of biological fluid
03/10/2005WO2004112700A8 Methods and compositions for modulating amyloid precursor protein translation
03/10/2005WO2004110963A3 Glycerophosphocholine and its derivatives for medical imaging neuropsychiatric disorders
03/10/2005WO2004106942A3 Method for measuring fluid chemistry in drilling and production operations
03/10/2005WO2004099404A3 Bioinformatic method for predicting functional equivalence between biological sequences
03/10/2005WO2004098497A3 Cd4+ human papillomavirus (hpv) epitopes
03/10/2005WO2004094996A3 System and method for determining differential protein expression, diagnostic biomarker discovery system and method of using the same, and protein biomarkers and therapeutic and diagnostic uses thereof
03/10/2005WO2004093647A3 Identification and monitoring of systematic lupus erythematosus
03/10/2005WO2004086937A3 Methods of detecting cancer cells in biological samples
03/10/2005WO2004082627A3 ENZYME REPLACEMENT THERAPY WITH 17-β-HYDROXYSTEROID DEHYDROGENASE-TYPE 2
03/10/2005WO2004078907A3 Streptococcus pyogenes antigens
03/10/2005WO2004075723A3 Methods for the early diagnosis of ovarian cancer
03/10/2005WO2004074508A3 Method of visualization and quantification of biopolymer molecules immobilized on solid support
03/10/2005WO2004070351A3 Protein fragment complementation assays for high-throughput and high-content screening
03/10/2005WO2004059283A3 Apparatus and method for edman degradation using a microfluidic system
03/10/2005WO2004049316A3 System and method of creating, aggregating, and transferring environmental emission reductions
03/10/2005WO2004048411A3 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion
03/10/2005WO2004037850A3 Multi-sided immersion formation of composite structures and method
03/10/2005WO2004035742A3 Sets of digital antibodies directed against short epitopes, and methods using same
03/10/2005WO2004025559B1 Diffraction grating-based optical identification element
03/10/2005WO2004013609A8 Use of biomarkers for detecting ovarian cancer
03/10/2005WO2004003166A3 Antibodies and uses thereof
03/10/2005WO2003087834A3 High throughput analysis of recombinant proteins in multi-well plates
03/10/2005WO2003085082A3 Nucleic acid reactions using labels with different redox potentials
1 ... 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 ... 3937